347 related articles for article (PubMed ID: 33125823)
21. Determination of urinary metabolites of cannabidiol, Δ
Sim YE; Kim JW; Ko BJ; Kim JY; Cheong JC; Pyo J
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan; 1214():123568. PubMed ID: 36527808
[TBL] [Abstract][Full Text] [Related]
22. Determination of Cannabinoids in Breast Milk Using QuEChERS and Ultra-Performance Liquid Chromatography and Tandem Mass Spectrometry.
Ramnarine RS; Poklis JL; Wolf CE
J Anal Toxicol; 2019 Oct; 43(9):746-752. PubMed ID: 31436289
[TBL] [Abstract][Full Text] [Related]
23. Quantification of Eight Cannabinoids Including Cannabidiol in Human Urine Via Liquid Chromatography Tandem Mass Spectrometry.
Scheidweiler KB; Barnes AJ
Methods Mol Biol; 2019; 1872():11-22. PubMed ID: 30350275
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of Cannabidiol, ∆9- and ∆8-Tetrahydrocannabinol and Metabolites in Workplace Drug Testing Urine Specimens.
Vikingsson S; Winecker RE; Cone EJ; Kuntz DJ; Dorsey B; Jacques M; Senter M; Flegel RR; Hayes ED
J Anal Toxicol; 2022 Oct; 46(8):866-874. PubMed ID: 35260906
[TBL] [Abstract][Full Text] [Related]
25. Urinary Pharmacokinetic Profile of Cannabinoids Following Administration of Vaporized and Oral Cannabidiol and Vaporized CBD-Dominant Cannabis.
Spindle TR; Cone EJ; Kuntz D; Mitchell JM; Bigelow GE; Flegel R; Vandrey R
J Anal Toxicol; 2020 Mar; 44(2):109-125. PubMed ID: 31682266
[TBL] [Abstract][Full Text] [Related]
26. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
[TBL] [Abstract][Full Text] [Related]
27. Are cannabinoids detected in hair after washing with Cannabio shampoo?
Cirimele V; Kintz P; Jamey C; Ludes B
J Anal Toxicol; 1999 Sep; 23(5):349-51. PubMed ID: 10488922
[TBL] [Abstract][Full Text] [Related]
28. Cannabis Use Surveillance by Sweat Analysis.
Gambelunghe C; Fucci N; Aroni K; Bacci M; Marcelli A; Rossi R
Ther Drug Monit; 2016 Oct; 38(5):634-9. PubMed ID: 27465974
[TBL] [Abstract][Full Text] [Related]
29. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls.
Möller I; Wintermeyer A; Bender K; Jübner M; Thomas A; Krug O; Schänzer W; Thevis M
Drug Test Anal; 2011 Sep; 3(9):609-20. PubMed ID: 20872894
[TBL] [Abstract][Full Text] [Related]
30. Quantification of six cannabinoids and metabolites in oral fluid by liquid chromatography-tandem mass spectrometry.
Desrosiers NA; Scheidweiler KB; Huestis MA
Drug Test Anal; 2015 Aug; 7(8):684-94. PubMed ID: 25428610
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoid concentrations in confiscated cannabis samples and in whole blood and urine after smoking CBD-rich cannabis as a "tobacco substitute".
Hädener M; Gelmi TJ; Martin-Fabritius M; Weinmann W; Pfäffli M
Int J Legal Med; 2019 May; 133(3):821-832. PubMed ID: 30612324
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips.
Andersson M; Scheidweiler KB; Sempio C; Barnes AJ; Huestis MA
Anal Bioanal Chem; 2016 Sep; 408(23):6461-71. PubMed ID: 27422645
[TBL] [Abstract][Full Text] [Related]
33. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
[TBL] [Abstract][Full Text] [Related]
34. Urinary cannabinoid mass spectrometry profiles differentiate dronabinol from cannabis use.
Koch CD; Xu L; Curtis SA; Roberts JD; Bunch DR; El-Khoury JM
Clin Chim Acta; 2020 Nov; 510():515-521. PubMed ID: 32795544
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous quantification of major cannabinoids and metabolites in human urine and plasma by HPLC-MS/MS and enzyme-alkaline hydrolysis.
Aizpurua-Olaizola O; Zarandona I; Ortiz L; Navarro P; Etxebarria N; Usobiaga A
Drug Test Anal; 2017 Apr; 9(4):626-633. PubMed ID: 27341312
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoids assessment in plasma and urine by high performance liquid chromatography-tandem mass spectrometry after molecularly imprinted polymer microsolid-phase extraction.
Sánchez-González J; Salgueiro-Fernández R; Cabarcos P; Bermejo AM; Bermejo-Barrera P; Moreda-Piñeiro A
Anal Bioanal Chem; 2017 Feb; 409(5):1207-1220. PubMed ID: 27815614
[TBL] [Abstract][Full Text] [Related]
37. Cannabidiol in urine is not a proof of CBD consumption-lesson learned from urine sample analysis in routine caseworks.
Deville M; Charlier C
Forensic Toxicol; 2023 Jul; 41(2):213-220. PubMed ID: 36481827
[TBL] [Abstract][Full Text] [Related]
38. Quality test of cannabidiol profiling in CBD oil products and evaluation of residual THC at high temperature based on liquid chromatography coupled with tandem mass spectrometry.
Takashina S; Minamoto K; Nunome M; Katehashi H; Katagi M; Inoue K
Biomed Chromatogr; 2023 Oct; 37(10):e5697. PubMed ID: 37394894
[TBL] [Abstract][Full Text] [Related]
39. Identification and quantification of cannabinoids in postmortem fluids and tissues by liquid chromatography-tandem mass spectrometry.
Cliburn KD; Huestis MA; Wagner JR; Kemp PM
J Chromatogr A; 2021 Aug; 1652():462345. PubMed ID: 34198104
[TBL] [Abstract][Full Text] [Related]
40. Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying THC, CBD and their metabolites in hair. Application to patients treated with medical cannabis.
Lo Faro AF; Venanzi B; Pilli G; Ripani U; Basile G; Pichini S; Busardò FP
J Pharm Biomed Anal; 2022 Aug; 217():114841. PubMed ID: 35636009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
